Norway Aquaculture Vaccines Market Size & Outlook
Norway aquaculture vaccines market, 2018-2030 (US$M)
Related Markets
Norway aquaculture vaccines market highlights
- The Norway aquaculture vaccines market generated a revenue of USD 42.6 million in 2023 and is expected to reach USD 71.2 million by 2030.
- The Norway market is expected to grow at a CAGR of 7.6% from 2024 to 2030.
- In terms of segment, inactivated (killed) was the largest revenue generating vaccine type in 2023.
- Other Vaccines is the most lucrative vaccine type segment registering the fastest growth during the forecast period.
Aquaculture vaccines market data book summary
| Market revenue in 2023 | USD 42.6 million |
| Market revenue in 2030 | USD 71.2 million |
| Growth rate | 7.6% (CAGR from 2023 to 2030) |
| Largest segment | Inactivated (killed) |
| Fastest growing segment | Other Vaccines |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Modified/ Attenuated Live, Inactivated (Killed), Other Vaccines |
| Key market players worldwide | Zoetis, Phibro Animal Health Corp Class A, Elanco Animal Health Inc, Merck & Co Inc, Choong Ang Vaccine Laboratories (CAVAC), Kyoto Biken Laboratories, Nissenken, KBNP, Vaxxinova, HIPRA |
Other key industry trends
- In terms of revenue, Norway accounted for 10.7% of the global aquaculture vaccines market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Norway aquaculture vaccines market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 6.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Aquaculture Vaccines Market Scope
Aquaculture Vaccines Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Norway aquaculture vaccines market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to aquaculture vaccines market will help companies and investors design strategic landscapes.
Inactivated (killed) was the largest segment with a revenue share of 34.74% in 2023. Horizon Databook has segmented the Norway aquaculture vaccines market based on modified/ attenuated live, inactivated (killed), other vaccines covering the revenue growth of each sub-segment from 2018 to 2030.
Norway is an important global player in the aquaculture industry and a key salmon exporter. The aquaculture sector in the country is modern and highly competitive. Norway has been receptive and quick to adopt the use of vaccines compared to other nations.
The country’s aquaculture sector is driven by high salmon prices and the country’s high production volume. In fact, as per Global Aquaculture Alliance, multivalent vaccines are widely used in Norwegian aquaculture sector, and this has almost eliminated the usage of antibacterials in Salmonid farming, resulting in exponential growth and sustainability in the industry.
The Norwegian Medicines Agency provides specific regulations and guidelines related to applications for autogenous vaccines. Also, autogenous vaccines are only to be used in case commercial vaccines are unavailable or do not offer enough protection. Recent challenges to the industry include Sea Lice infestations and other aquatic diseases which present opportunities for market players.
Reasons to subscribe to Norway aquaculture vaccines market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Norway aquaculture vaccines market databook
-
Our clientele includes a mix of aquaculture vaccines market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway aquaculture vaccines market , including forecasts for subscribers. This country databook contains high-level insights into Norway aquaculture vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Norway aquaculture vaccines market size, by vaccine type, 2018-2030 (US$M)
Norway Aquaculture Vaccines Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
